Natera’s non-invasive prenatal testing (NIPT) for fetal sex determination typically provides results within a few business days of the lab receiving the sample. This screening, utilizing a blood sample from the pregnant person, analyzes cell-free DNA in maternal blood to determine the presence of Y-chromosomal material, indicating a male fetus. Absence of Y-chromosomal material suggests a female fetus.
Early knowledge of fetal sex can be valuable for various reasons. Medically, it allows for targeted screening and diagnostic testing for sex-linked genetic conditions. It also allows prospective parents to begin bonding with their child and make informed decisions regarding pregnancy and childbirth. The development of NIPT has significantly advanced prenatal care, offering a safer and earlier alternative to traditional invasive procedures like amniocentesis or chorionic villus sampling for sex determination.